- Harder-to-tackle emissions from across our supply chain, our own operations, logistics, and disposal beyond 2030
GlaxoSmithKline plc
Greenhouse gas emissions & sustainability report data
In its 2024 reporting, GlaxoSmithKline plc disclosed greenhouse gas emissions of 9.71m tonnes CO₂e per annum (2022). By scope: Scope 3: 5.5m tonnes CO₂e per annum (2022). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
9.71m tonnes CO₂e per annum (2022)
2024
Renewable Energy
100% imported renewable electricity by 2025; 100% renewable electricity (imported and generated) by 2030 (Scope 2)
of total energy
📊 Emissions by Scope (2024)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 5.5m tonnes CO₂e per annum (2022) |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2024 | 9.71m tonnes CO₂e per annum (2022) |
| 2021 | 840 (thousand tonnes CO2e) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- 80% absolute reduction in greenhouse gas emissions from a 2020 baseline across all scopes by 2030
- 100% imported renewable electricity by 2025 and 100% renewable electricity (imported and generated) by 2030 (Scope 2)
🎯 Climate & Sustainability Targets
🔜 Short-term
- 80% absolute reduction in greenhouse gas emissions from a 2020 baseline across all scopes by 2030
🔭 Long-term
- Net zero greenhouse gas emissions across the full value chain by 2045: 90% absolute reduction in emissions from a 2020 baseline, across all scopes and all residual emissions neutralised
🌱 ESG Focus Areas
Climate Change